Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2016-06-19 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
关于收购美国PTS公司签署《并购协议》暨与子公司签订《股份与权利义务转让协议》的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the signing of a 'Contribution and Assignment Agreement' related to the transfer of shares and rights obligations between the company and its subsidiary, as part of a merger and acquisition transaction involving the acquisition of a US company (PTS). It details the transaction overview, board approval, company information, and risk warnings. The document is relatively short (3359 characters) and primarily serves as a formal announcement of the transaction and related agreements, rather than a full merger agreement or detailed financial report. It does not contain comprehensive financial statements or detailed merger communications typical of a full M&A filing or annual/interim report. Therefore, it fits best as a Regulatory Filing (RNS) because it is a formal disclosure of a corporate transaction without the full merger documentation or financial data. It is not a report publication announcement since it contains substantive transaction details and board resolutions, but not a full report or financial statements.
2016-06-19 Chinese
关于召开2016年第一次临时股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about convening the 2016 first extraordinary general meeting (临时股东大会) of the company 三诺生物传感股份有限公司. It includes information about the meeting date, agenda items, voting procedures (both onsite and online), registration methods, and attachments such as proxy forms and shareholder registration forms. The document does not contain financial statements or results but is a formal announcement to shareholders about the meeting and how to participate and vote. This fits the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings. The document length (5727 characters) and content confirm it is the meeting notice itself, not just a brief announcement or voting results. Therefore, the correct classification is AGM Information (AGM-R).
2016-06-19 Chinese
重大资产重组进展公告
Capital/Financing Update Classification · 95% confidence The document is titled '重大资产重组进展公告' which translates to 'Major Asset Restructuring Progress Announcement'. It discusses the company's ongoing major asset restructuring, stock suspension due to this, and periodic progress updates. It references multiple previous announcements about the progress of the asset restructuring. The document does not contain financial statements or detailed financial data but is an update on the progress of a major asset restructuring event. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as major asset restructurings.
2016-06-13 Chinese
重大资产重组进展公告
Capital/Financing Update Classification · 95% confidence The document is titled '重大资产重组进展公告' which translates to 'Major Asset Restructuring Progress Announcement'. It details the progress of a significant asset restructuring, including stock suspension dates and ongoing due diligence activities. The document is relatively short (943 characters) and serves as an update on the status of a major asset restructuring rather than the full restructuring report or proposal itself. It also mentions that further announcements will be made. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as major asset restructurings. It is not a full report or proposal, so it is not classified as TAR or MA. Therefore, the appropriate classification is CAP with high confidence.
2016-06-06 Chinese
独立董事关于第二届董事会第三十二次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on a specific board meeting matter regarding the waiver of a preemptive purchase right related to a subsidiary's equity. It references compliance with regulatory guidelines and company bylaws, and it is signed by independent directors. The content is focused on governance and board-level decision commentary rather than financial results, audit, or shareholder voting outcomes. It does not contain financial statements or earnings data, nor is it a general regulatory announcement or a report publication notice. This fits the category of Board/Management Information (MANG), which covers announcements of board decisions and management-related information.
2016-06-01 Chinese
关于放弃参股子公司股权优先购买权的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the waiver of preemptive rights to purchase equity in a subsidiary company. It details the transfer of shares among shareholders, the background of the transaction, and the board's approval of the waiver. There are no financial statements, quarterly or annual results, or detailed financial data presented. The document is a formal announcement of a corporate action related to shareholding and equity transfer, not a full financial report or earnings release. It fits best under the category of Capital/Financing Update (CAP), as it concerns changes in shareholding and capital structure related to a subsidiary and a planned major asset restructuring.
2016-06-01 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.